In this study, we examine genomic alterations (somatic mutations and CNVs) occurring in APE2 in vivo from 14 cancer types and if APE2 is differentially expressed in 6 types of tumor tissue compared with non-malignant tissue. This evidence concerns the gene APEX2 and cancer.